Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FACTSET RESEARCH SYSTEMS INC Director's Dealing 2014

Jul 2, 2014

30555_dirs_2014-07-01_958c286b-4c49-4dfa-bc0f-a2856c63684f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FACTSET RESEARCH SYSTEMS INC (FDS)
CIK: 0001013237
Period of Report: 2014-07-01

Reporting Person: Snow Frederick Philip (President)

Holdings (Non-Derivative)

Security Shares Ownership
FactSet Common Stock 3028 Direct
FactSet Common Stock 778 Direct
FactSet Common Stock 424 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $35.8000 2015-10-24 FactSet Common Stock (2116) Direct
Non-Qualified Stock Option (right to buy) $66.4600 2016-10-23 FactSet Common Stock (6250) Direct
Non-Qualified Stock Option (right to buy) $88.4000 2017-11-08 FactSet Common Stock (7334) Direct
Non-Qualified Stock Option (right to buy) $94.8400 2021-11-01 FactSet Common Stock (4729) Direct
Non-Qualified Stock Option (right to buy) $92.2200 2022-11-01 FactSet Common Stock (7146) Direct
Non-Qualified Stock Option (right to buy) $92.2200 2022-11-01 FactSet Common Stock (11711) Direct

Footnotes

F1: Represents restricted stock awards which vest over 5 years at a rate of 60% after 3 years and the remaining 40% after 5 years, subject to continued employment.

F2: Represents shares acquired through the FactSet Research Systems Inc. Employee Stock Purchase Plan.

F3: Twenty percent of this option grant is exercisable one year after the grant date, with the remainder vesting at a rate of 1.67% per month thereafter.

F4: These options shall become exercisable based on the achievement by the issuer of certain financial performance criteria. Options that do not vest at the end of a two-year performance period will be forfeited. Options that become exercisable vest 40% after the two-year performance period with the remainder vesting at 1.67% per month thereafter.